Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.5299 USD
-2.91%
Market Closed
Updated:
May 12, 2024
Atara Biotherapeutics Inc
Net Change in Cash
|
Atara Biotherapeutics Inc
Net Change in Cash Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Net Change in Cash
-$67.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Change in Cash
$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Change in Cash
$673m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-17%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Change in Cash
-$21.9B
|
CAGR 3-Years
-140%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Change in Cash
-$139.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Change in Cash
-$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Atara Biotherapeutics Inc's Net Change in Cash?
Net Change in Cash
-67.1m
USD
-67.1m
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Net Change in Cash amounts to -67.1m USD.
What is Atara Biotherapeutics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-29%
-29%
Over the last year, the Net Change in Cash growth was -366%.
You don't have any saved screeners yet
